SectorBiological Technology
Established Date02/07/2018
Listing Date16/07/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees103
Fiscal Year Ends31/12
Security TypeCommon stock
Office address3115 Merryfield Row, Suite 300, San Diego, CA 92121
Business
IntroductionErasca, Inc., was incorporated in Delaware on July 2, 2018. The company is a clinical-stage precision oncology company focused on discovering, developing and commercializing therapies for cancer patients driven by the RAS/MAPK pathway. Co-founded by leading pioneers in precision oncology and RAS targeting, the company aims to create new therapies and combination programs aimed at completely shutting down the RAS/MAPK pathway to treat cancer.
